Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Protein Engineering. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116179502A details a novel ketoreductase mutant enabling >99% ee chiral alcohol synthesis. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN119614533B reveals thermostable enzyme mutants improving R-chiral amine synthesis efficiency and supply chain stability for pharmaceutical intermediates.
Patent CN110577941B details mutated amine dehydrogenase for asymmetric reductive amination, offering high optical purity and scalable biocatalysis for pharmaceutical intermediates.
Novel transaminase mutant CN113621592A enables 99% yield of L-glufosinate. Reduces cost and improves supply chain reliability for agrochemical intermediates.
Patent CN117467631B reveals novel P450 mutant for gamma-lactone. Enables cost reduction in fine chemical manufacturing with high selectivity.
Patent CN117089533A details novel carbonyl reductase mutants enabling cost reduction in chiral alcohol manufacturing with high stereoselectivity and supply reliability.
Patent CN108949736B reveals a novel PGA mutant for cephradine synthesis, offering superior Vs/Vh ratios and reduced hydrolysis for efficient API manufacturing.
Patent CN118879653A reveals high-efficiency DAAO mutant for L-glufosinate production. Achieves 99% conversion with reduced costs and enhanced supply chain reliability for global agrochemical manufacturers.
Discover the CN110699345A patent technology for enhanced stereoselectivity in chiral epoxide synthesis. Reliable supplier for pharmaceutical intermediates with cost-effective biocatalytic solutions.
Patent CN110387359B discloses engineered enzymes for efficient statin production, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN108359649A reveals high-selectivity alcohol dehydrogenase mutants for synthesizing chiral biaryl alcohols, offering cost reduction and supply reliability.
Patent CN117210431A reveals thermostable transaminase mutant for high-purity L-glufosinate. Achieves cost reduction in agrochemical manufacturing and supply reliability.
Patent CN115948357A reveals novel ketoreductase mutants for eslicarbazepine production, offering superior stereoselectivity and cost-effective biocatalytic manufacturing solutions.
Patent CN117025574A reveals high-activity dipeptidase for L-Carnosine. Green enzymatic route offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115820584A reveals high-efficiency mutants for L-phenylglycine and L-2-aminobutyric acid synthesis, offering cost reduction and supply reliability.
Patent CN108570460B discloses novel SDR mutants enabling high-selectivity biocatalytic reduction of acetophenone derivatives, offering a greener alternative for pharmaceutical intermediate manufacturing.
Patent CN109609475A reveals mutant dehydrogenase for high-purity L-Glufosinate-ammonium. Offers scalable agrochemical intermediate manufacturing with reduced waste.
Patent CN109852593B details a high-activity CmCR mutant for R-3HB production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111411095B discloses a novel recombinant (R)-ω-transaminase mutant with high activity and stereoselectivity for efficient sitagliptin intermediate production, ensuring supply chain stability.
Patent CN108546691B discloses a novel 7β-HSDH mutant utilizing cheap NADH for ursodeoxycholic acid production, offering significant cost reduction and scalable biocatalysis solutions.